Cyclic nigerosyl-1,6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 194, 111-121
Abstract
No abstract availableKeywords
Funding Information
- Università degli Studi di Torino
This publication has 48 references indexed in Scilit:
- Evolution of Cyclodextrin NanospongesInternational Journal of Pharmaceutics, 2017
- pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer TherapyACS Applied Materials & Interfaces, 2017
- Formulation and Application of Biodegradable Nanoparticles Based Biopharmaceutical Delivery - An Efficient Delivery SystemCurrent Pharmaceutical Design, 2016
- Cyclodextrin-Based Nanosponges as a Nanotechnology Strategy for Imiquimod Delivery in Pathological Scarring Prevention and TreatmentJournal of Nanopharmaceutics and Drug Delivery, 2014
- Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug deliveryBiomaterials, 2013
- Nanosponge formulations as oxygen delivery systemsInternational Journal of Pharmaceutics, 2010
- Cyclodextrin-based Nanosponges for Drug DeliveryJournal of Inclusion Phenomena and Macrocyclic Chemistry, 2006
- 6-α-Glucosyltransferase and 3-α-isomaltosyltransferase from Bacillus globisporus N75Journal of Bioscience and Bioengineering, 2003
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- X-ray structure determination and modeling of the cyclic tetrasaccharide cyclo-{→6)-α-d-Glcp-(1→3)-α-d-Glcp-(1→6)-α-d-Glcp-(1→3)-α-d-Glcp-(1→}Carbohydrate Research, 2000